UPDATED Apr 01, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MBLY | US$32.10 | 2.9% | -26.0% | US$25.9b | US$38.22 | PS12.4x | E42.2% | n/a | ||
RIVN | US$11.09 | 4.1% | -27.2% | US$10.7b | US$17.84 | PS2.4x | E15.7% | n/a | ||
LCID | US$2.86 | -2.1% | -63.8% | US$6.6b | US$3.38 | PS11.1x | E28.6% | n/a | ||
QS | US$6.13 | 5.3% | -23.6% | US$3.1b | US$7.02 | PB2.3x | E-3.3% | n/a |